Literature DB >> 16864919

Crimean-Congo hemorrhagic fever: case series from a medical center in Golestan province, Northeast of Iran (2004).

Ali Jabbari1, Sima Besharat, Abdollah Abbasi, Abdolvahhab Moradi, Khodaberdi Kalavi.   

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a widely distributed lethal disease, worldwide. Humans are usually infected with CCHF virus through a tick bite or close contact with viral contaminated tissues or with blood of domestic animals or of infected patients. The present study reports six cases of CCHF, who were in contact with both infected tissues and blood from sheep. In some regions like Golestan province (North of Iran), clinician suspicion may have an important role in early diagnosis and treatment of the disease. Conservative therapy (intensive monitoring) and prescription of antiviral medication (Ribavirin) accompanied with corticosteroids, was useful at the early stage of CCHF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16864919

Source DB:  PubMed          Journal:  Indian J Med Sci        ISSN: 0019-5359


  9 in total

1.  Crimean-congo hemorrhagic fever: treatment and control strategy in admitted patients.

Authors:  Ali Jabbari; Shabnam Tabasi; Abdollah Abbasi; Ebrahim Alijanpour
Journal:  Caspian J Intern Med       Date:  2012

Review 2.  Recent advances in research on Crimean-Congo hemorrhagic fever.

Authors:  Anna Papa; Ali Mirazimi; Iftihar Köksal; Augustin Estrada-Pena; Heinz Feldmann
Journal:  J Clin Virol       Date:  2014-10-22       Impact factor: 3.168

3.  Crimean congo hemorrhagic fever appearance in the north of Iran.

Authors:  Mahmood Sadeghi; Seyed Ahmad Asgharzadeh; Masomeh Bayani; Ebrahim Alijanpour; Mostafa Javaniyan; Ali Jabbari
Journal:  Caspian J Intern Med       Date:  2013

Review 4.  Crimean-Congo hemorrhagic fever in Iran.

Authors:  Maryam Keshtkar-Jahromi; Mohammad M Sajadi; Hossein Ansari; Masoud Mardani; Kourosh Holakouie-Naieni
Journal:  Antiviral Res       Date:  2013-07-18       Impact factor: 5.970

5.  Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey.

Authors:  Hürrem Bodur; Esragül Akinci; Sibel Ascioglu; Pinar Öngürü; Yavuz Uyar
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

6.  Facts about Crimean-Congo hemorrhagic fever and the role of intensive care in treatment and outcome.

Authors:  Ali Jabbari; Ebrahim Alijanpour; Shabnam Tabasi
Journal:  Anesth Essays Res       Date:  2013 May-Aug

Review 7.  Ribavirin for treating Crimean Congo haemorrhagic fever.

Authors:  Samuel Johnson; Nicholas Henschke; Nicola Maayan; Inga Mills; Brian S Buckley; Artemisia Kakourou; Rachel Marshall
Journal:  Cochrane Database Syst Rev       Date:  2018-06-05

Review 8.  Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease.

Authors:  Aura R Garrison; Darci R Smith; Joseph W Golden
Journal:  Viruses       Date:  2019-06-28       Impact factor: 5.048

Review 9.  Crimean-Congo haemorrhagic fever virus: Past, present and future insights for animal modelling and medical countermeasures.

Authors:  E J Mendoza; B Warner; D Safronetz; C Ranadheera
Journal:  Zoonoses Public Health       Date:  2018-04-20       Impact factor: 2.702

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.